Clay B Siegall is President & CEO of Seagen Inc.. Currently has a direct ownership of 666,060 shares of SGEN, which is worth approximately $0. The most recent transaction as insider was on May 12, 2022, when has been sold 17,043 shares (Common Stock) at a price of $125.79 per share, resulting in proceeds of $2,143,839. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 666K
0% 3M change
0% 12M change
Total Value Held $0

CLAY B SIEGALL Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 12 2022
SELL
Open market or private sale
$2,143,839 $125.79 p/Share
17,043 Reduced 2.49%
666,060 Common Stock
May 12 2022
BUY
Exercise of conversion of derivative security
$444,822 $26.1 p/Share
17,043 Added 2.46%
676,653 Common Stock
Apr 20 2022
SELL
Open market or private sale
$272,043 $144.32 p/Share
1,885 Reduced 0.28%
666,060 Common Stock
Apr 07 2022
SELL
Open market or private sale
$2,632,632 $154.47 p/Share
17,043 Reduced 2.49%
667,945 Common Stock
Apr 07 2022
BUY
Exercise of conversion of derivative security
$444,822 $26.1 p/Share
17,043 Added 2.49%
668,419 Common Stock
Mar 07 2022
SELL
Open market or private sale
$2,294,329 $134.62 p/Share
17,043 Reduced 2.49%
667,945 Common Stock
Mar 07 2022
BUY
Exercise of conversion of derivative security
$444,822 $26.1 p/Share
17,043 Added 2.47%
671,945 Common Stock
Feb 07 2022
SELL
Open market or private sale
$2,381,248 $139.72 p/Share
17,043 Reduced 2.49%
667,945 Common Stock
Feb 07 2022
BUY
Exercise of conversion of derivative security
$444,822 $26.1 p/Share
17,043 Added 2.49%
668,245 Common Stock
Jan 07 2022
SELL
Open market or private sale
$2,478,709 $145.43 p/Share
17,044 Reduced 2.49%
667,945 Common Stock
Jan 07 2022
BUY
Exercise of conversion of derivative security
$444,848 $26.1 p/Share
17,044 Added 2.46%
676,108 Common Stock
Dec 20 2021
SELL
Open market or private sale
$183,866 $149.85 p/Share
1,227 Reduced 0.18%
667,945 Common Stock
Dec 07 2021
SELL
Open market or private sale
$6,750,086 $148.52 p/Share
45,449 Reduced 6.36%
669,172 Common Stock
Dec 07 2021
BUY
Exercise of conversion of derivative security
$1,186,219 $26.1 p/Share
45,449 Added 6.31%
674,520 Common Stock
Sep 23 2021
BUY
Grant, award, or other acquisition
$118,681 $166.22 p/Share
714 Added 0.11%
669,172 Common Stock
Aug 31 2021
SELL
Open market or private sale
$2,404,080 $167.52 p/Share
14,351 Reduced 2.1%
668,458 Common Stock
Aug 31 2021
SELL
Open market or private sale
$1,765,407 $169.23 p/Share
10,432 Reduced 1.5%
682,809 Common Stock
Aug 30 2021
SELL
Open market or private sale
$5,970,043 $167.2 p/Share
35,706 Reduced 4.9%
693,241 Common Stock
Aug 27 2021
SELL
Open market or private sale
$2,422,976 $169.51 p/Share
14,294 Reduced 1.92%
728,947 Common Stock
Aug 16 2021
SELL
Open market or private sale
$431,040 $154.55 p/Share
2,789 Reduced 0.39%
712,420 Common Stock
Aug 16 2021
BUY
Grant, award, or other acquisition
-
30,821 Added 3.98%
743,241 Common Stock
Aug 06 2021
SELL
Open market or private sale
$926,069 $159.86 p/Share
5,793 Reduced 0.8%
715,209 Common Stock
Aug 06 2021
BUY
Exercise of conversion of derivative security
$89,560 $15.46 p/Share
5,793 Added 0.8%
718,885 Common Stock
Aug 05 2021
SELL
Open market or private sale
$3,850,175 $163.42 p/Share
23,560 Reduced 3.19%
715,209 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$364,238 $15.46 p/Share
23,560 Added 3.16%
722,394 Common Stock

Also insider at

NRIX
Nurix Therapeutics, Inc. Healthcare
IMNM
Immunome Inc. Healthcare
TALS
Talaris Therapeutics, Inc. Healthcare
STTK
Shattuck Labs, Inc. Healthcare
CBS

Clay B Siegall

President & CEO
Bothell, WA

Track Institutional and Insider Activities on SGEN

Follow Seagen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGEN shares.

Notify only if

Insider Trading

Get notified when an Seagen Inc. insider buys or sells SGEN shares.

Notify only if

News

Receive news related to Seagen Inc.

Track Activities on SGEN